The affirmation is a result of several factors, including VCH’s wide array of services, solid physician alignment, favorable liquidity metrics, healthy debt coverage and strong market position. Moody’s also acknowledged VCH’s unfavorable payer mix, heightened competition and a material decline in profitability in recent years.
The outlook is stable, reflecting Moody’s expectation that the hospital will achieve stable operating results going forward.
More articles on healthcare finance:
Donations to USC medical school fall 55% after dean, faculty scandals
U of Texas Health renames cancer center after donors of $25M gift
6 latest hospital credit downgrades
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
